KMITL
Permanent URI for this communityhttps://dspace.kmitl.ac.th/handle/123456789/1
Browse
4 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Towards reproducible computational drug discovery(2020-01-28) ;Schaduangrat, Nalini ;Lampa, Samuel ;Simeon, Saw ;Gleeson, Matthew PaulSpjuth, OlaThe reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Investigation of Factors Affecting the Performance of in silico Volume Distribution QSAR Models for Human, Rat, Mouse, Dog & Monkey(2019-10-01) ;Simeon, Saw ;Montanari, DinoGleeson, Matthew PaulVolume of distribution (Vd<inf>ss</inf>) is a measure of how effectively a drug molecule is distributed throughout the body. Along with the clearance, it determines the half-life and therefore the drug dosing interval. A number of different pre-clinical approaches are available to predict the Vd<inf>ss</inf> in human including quantitative structure activity relationship (QSAR) models. Vd<inf>ss</inf> QSAR models have been reported for human and rat, but not important pre-clinical species including dog, mouse and monkey. In this study, we have generated Vd<inf>ss</inf> QSAR model on the human and commonly used pre-clinical species, each of which differs in terms of size, chemical diversity and data quality. We discuss the model performance by species, assess the effect the domain of applicability and the relative merits of building chemical series-specific models. In addition, we compare the intrinsic variability of the experimental logVd<inf>ss</inf> data (∼1.2 fold error) to in-vivo interspecies differences (∼2 fold error) and in silico based models (∼3 fold error). This prompted us to explore whether one species could be used to predict another, particularly where little data for that species is available. i. e. does the expansion in domain of applicability prove beneficial over and above any deterioration due to the use of response values from an alternative species. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies(2019-08-01) ;Simeon, Saw ;Jongkon, Nathjanan ;Chotpatiwetchkul, WarotGleeson, M. PaulProtein kinases are an important class of enzymes that play an essential role in virtually all major disease areas. In addition, they account for approximately 50% of the current targets pursued in drug discovery research. In this work, we explore the generation of structure-based quantum mechanical (QM) quantitative structure–activity relationship models (QSAR) as a means to facilitate structure-guided optimization of protein kinase inhibitors. We explore whether more accurate, interpretable QSAR models can be generated for a series of 76 N-phenylquinazolin-4-amine inhibitors of epidermal growth factor receptor (EGFR) kinase by comparing and contrasting them to other standard QSAR methodologies. The QM-based method involved molecular docking of inhibitors followed by their QM optimization within a ~ 300 atom cluster model of the EGFR active site at the M062X/6-31G(d,p) level. Pairwise computations of the interaction energies with each active site residue were performed. QSAR models were generated by splitting the datasets 75:25 into a training and test set followed by modelling using partial least squares (PLS). Additional QSAR models were generated using alignment dependent CoMFA and CoMSIA methods as well as alignment independent physicochemical, e-state indices and fingerprint descriptors. The structure-based QM-QSAR model displayed good performance on the training and test sets (r<sup>2</sup> ~ 0.7) and was demonstrably more predictive than the QSAR models built using other methods. The descriptor coefficients from the QM-QSAR models allowed for a detailed rationalization of the active site SAR, which has implications for subsequent design iterations. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, PepBio: Predicting the bioactivity of host defense peptides(2017-01-01) ;Simeon, Saw ;Li, Hao ;Win, Thet Su ;Malik, Aijaz AhmadKandhro, Abdul HafeezHost defense peptides (HDPs) represents a class of ubiquitous and rapid responding immune molecules capable of direct inactivation of a wide range of pathogens. Recent research has shown HDPs to be promising candidates for development as a novel class of broad-spectrum chemotherapeutic agent that is effective against both pathogenic microbes and malignant neoplasm. This study aims to quantitatively explore the relationship between easy-to-interpret amino acid composition descriptors of HDPs with their respective bioactivities. Classification models were constructed using the C4.5 decision tree and random forest classifiers. Good predictive performance was achieved as deduced from the accuracy, sensitivity and specificity in excess of 90% and Matthews correlation coefficient in excess of 0.5 for all three evaluated data subsets (e.g. training, 10-fold cross-validation and external validation sets). The source code and data set used for the construction of classification models are available on GitHub at https://github.com/chaninn/pepbio/.
